Tolerance of Telaprevir or Boceprevir retreatment for chronic hepatitis C in patients with severe hepatic fibrosis. Results in a prospective multicentric cohort

被引：0
|
作者：
Guivarch, Mathieu [1 ]
Berard, Emilie [1 ]
Palacin, Anais [1 ]
Barange, Karl [1 ]
Metivier, Sophie [1 ]
Nicot, Florence [1 ]
Abravanel, Florence [1 ]
Bonnet, Delphine [1 ]
Alric, Laurent [1 ]
机构：
[1] CHU Purpan, Toulouse, France
来源：
HEPATOLOGY | 2013年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1971
引用
收藏
页码：1162A / 1162A
页数：1
相关论文
共 50 条
  • [1] BOCEPREVIR AND TELAPREVIR EFFECTIVENESS AND SAFETY IN A BRAZILIAN COHORT OF CHRONIC HEPATITIS C GENOTYPE 1 PATIENTS: A MULTICENTRIC LONGITUDINAL STUDY
    Borba, H. H.
    Wiens, A.
    Steimbach, L. M.
    Tonin, F. S.
    Pedroso, M. L.
    Minowa, E.
    Piedade, A.
    Clark, O.
    Fernandez-Llimos, F.
    Pontarolo, R.
    [J]. VALUE IN HEALTH, 2017, 20 (09) : A882 - A882
  • [2] Chronic hepatitis C, alcohol and hepatic fibrosis.
    Jenkins, PJ
    Cromie, SL
    Roberts, SK
    Finch, CF
    Dudley, FJ
    [J]. HEPATOLOGY, 1996, 24 (04) : 105 - 105
  • [3] The natural history of hepatitis C with severe hepatic fibrosis.
    Ryder, SD
    Lawson, A
    Zaitoun, A
    Rye, K
    Irving, W
    Neal, K
    McKendrick, M
    Gleeson, D
    Hagan, S
    Taguri, N
    [J]. HEPATOLOGY, 2004, 40 (04) : 685A - 685A
  • [4] Previous and silent hepatitis B infection in patients with chronic hepatitis C: Risk factors for severe hepatic fibrosis.
    Metwally, MA
    Roberts, LR
    Petrovic, LM
    Zein, CO
    Montoya, DP
    Zein, NN
    [J]. HEPATOLOGY, 2002, 36 (04) : 567A - 567A
  • [5] Retreatment of Chronic Hepatitis C Infection with Telaprevir: Preliminary Results in Turkey
    Aygen, Bilgehan
    Yildiz, Orhan
    Akhan, Sila
    Celen, Mustafa Kemal
    Ural, Onur
    Koruk, Suda Tekin
    Kose, Sukran
    Korkmaz, Fatime
    Kuruuzum, Ziya
    Tuna, Nazan
    Taheri, Serpil
    Sayan, Murat
    Demir, Nazlim Aktug
    Sumer, Sua
    Altinok, Elif Sargin
    [J]. BALKAN MEDICAL JOURNAL, 2015, 32 (03) : 266 - 272
  • [6] Sustained virologic esponse to Telaprevir or Boceprevir in previously non responder HCV genotype 1 patients with severe liver fibrosis : results of a prospective multicentric study
    Alric, Laurent
    Guivarch, Mathieu
    Berard, Emilie
    Metivier, Sophie
    Barange, Karl
    Nicot, Florence
    Abravanel, Florence
    Bonnet, Delphine
    [J]. HEPATOLOGY, 2013, 58 : 1154A - 1155A
  • [7] Telaprevir or boceprevir triple therapy in patients with chronic hepatitis C and varying severity of cirrhosis
    Saxena, V.
    Manos, M. M.
    Yee, H. S.
    Catalli, L.
    Wayne, E.
    Murphy, R. C.
    Shvachko, V. A.
    Pauly, M. P.
    Chua, J.
    Monto, A.
    Terrault, N. A.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 39 (10) : 1213 - 1224
  • [8] Chronic hepatitis C: Hepatic expression of fibroblast activation protein correlates with hepatic fibrosis.
    Levy, MT
    McCaughan, GW
    Marinos, G
    Gorrell, MD
    [J]. HEPATOLOGY, 1999, 30 (04) : 323A - 323A
  • [9] Cost-effectiveness of boceprevir or telaprevir for untreated patients with genotype 1 chronic hepatitis C
    Camma, Calogero
    Petta, Salvatore
    Enea, Marco
    Bruno, Raffaele
    Bronte, Fabrizio
    Capursi, Vincenza
    Cicchetti, Americo
    Colombo, Giorgio L.
    Di Marco, Vito
    Gasbarrini, Antonio
    Craxi, Antonio
    [J]. HEPATOLOGY, 2012, 56 (03) : 850 - 860
  • [10] Renal impairment is frequent in chronic hepatitis C patients under triple therapy with telaprevir or boceprevir
    Mauss, Stefan
    Eisenbach, Christoph
    Heyne, Renate
    Moog, Gero
    Lutz, Thomas
    Naumann, Uwe
    Geissler, Michael
    Pape, Stefan
    Mordeja, Matthias
    Herold, Christoph
    Simon, Karl-Georg
    Isernhagen, Konrad
    Alshuth, Ulrich
    Buggisch, Peter
    Hueppe, Dietrich
    [J]. HEPATOLOGY, 2013, 58 : 1112A - 1112A
12345